• LevelJump Healthcare Corp. (JUMP) has closed the second tranche of a previously announced non-brokered private placement for gross proceeds of $177,500
  • The company issued 1,183,334 units at a price of $0.15 per unit
  • Net proceeds from the first two tranches of the offering total $477,785
  • LevelJump Healthcare is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology
  • Shares in LevelJump Healthcare Corp. (JUMP) opened trading at C$0.095

LevelJump Healthcare Corp. (JUMP) has closed the second tranche of a non-brokered private placement for gross proceeds of $177,500.

The company issued 1,183,334 units at a price of $0.15 per unit. Each unit consists of one common share and one share purchase warrant. Each warrant entitles the holder to acquire one additional share for a price of $0.20 until January 31, 2024.

Net proceeds from the first two tranches of the offering total $477,785.

Net proceeds from the financing will be used towards acquisitions and for general working capital purposes.

The securities issued are subject to a statutory hold period of four months and one day from the closing date in accordance with applicable securities laws.

“We are very excited to close this financing, and to have the support of our strategic investors who believe in the vision of the Company,” said Mitch Geisler, CEO.

“We have now strengthened our balance sheet and are in a stronger position post closing of our acquisition of the IHF centers, as well as to continue our efforts to close the acquisition of Telehospital.”

LevelJump Healthcare is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology. The company provides radiology solutions for hospitals, emergency rooms, and private clinics.

Shares in LevelJump Healthcare Corp. (JUMP) opened trading at C$0.095.

More From The Market Online

Reliq Health expands contract with U.S. health group

Reliq Health Technologies (TSXV:RHT) reveals it has expanded an existing contract with a large U.S. health group.

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.